ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Gujarat Themis Biosyn incorporated a wholly owned pharmaceutical subsidiary in Ireland with €1,00,000 capital. The move marks an international expansion into European markets.
Gujarat Themis Biosyn Limited incorporated a wholly owned subsidiary, Themis Biosyn Japan Limited, in Japan. This strategic expansion marks the company's direct entry into the Japanese market.
Gujarat Themis Biosyn incorporated a wholly owned subsidiary in Japan named Themis Biosyn Japan Limited. This expansion strengthens the company's international pharmaceutical business footprint.